肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

中国前列腺癌放射治疗指南（2020年版）

2021-03-20 中国医师协会放射肿瘤治疗医师分会 中华肿瘤防治杂志

前列腺癌泌尿生殖系肿瘤

前列腺癌是威胁我国男性健康的主要恶性肿瘤之一，放射治疗是前列腺癌的主要治疗方式，贯彻前列腺癌整个治疗过程。

中文标题：

中国前列腺癌放射治疗指南（2020年版）

发布机构：

中国医师协会放射肿瘤治疗医师分会

发布日期：

2021-03-20

简要介绍：

前列腺癌是威胁我国男性健康的主要恶性肿瘤之一，放射治疗是前列腺癌的主要治疗方式，贯彻前列腺癌整个治疗过程。国际上多应用欧洲及美国前列腺癌指南，近年关于中国前列腺癌的研究逐渐增多，本指南结合最新版国内外各项研究，联合国内多家泌尿肿瘤诊疗权威单位，制定我国前列腺癌放射治疗指南，进一步规范、提高我国前列腺癌放射治疗水平。

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1227258, encodeId=b27f122e258aa, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b173099865, createdName=xuexuehong, createdTime=Sat Jun 18 20:53:22 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200063, encodeId=351e12000634b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKic4Sia2vW3FdKIZE7aLtjvkgUXebicPbmmEPH4JrxqOgy91XW1cnqGmrIqiag2sZX8rhc41g6daIuLg/132, createdBy=ad2d2367463, createdName=王振超, createdTime=Sun Mar 06 22:19:58 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077022, encodeId=f55a10e702281, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:29 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076431, encodeId=5d8610e6431b3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 03 07:02:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075676, encodeId=1eca10e567684, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:07 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2022-06-18 xuexuehong

    非常实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1227258, encodeId=b27f122e258aa, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b173099865, createdName=xuexuehong, createdTime=Sat Jun 18 20:53:22 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200063, encodeId=351e12000634b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKic4Sia2vW3FdKIZE7aLtjvkgUXebicPbmmEPH4JrxqOgy91XW1cnqGmrIqiag2sZX8rhc41g6daIuLg/132, createdBy=ad2d2367463, createdName=王振超, createdTime=Sun Mar 06 22:19:58 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077022, encodeId=f55a10e702281, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:29 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076431, encodeId=5d8610e6431b3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 03 07:02:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075676, encodeId=1eca10e567684, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:07 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2022-03-06 王振超

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1227258, encodeId=b27f122e258aa, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b173099865, createdName=xuexuehong, createdTime=Sat Jun 18 20:53:22 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200063, encodeId=351e12000634b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKic4Sia2vW3FdKIZE7aLtjvkgUXebicPbmmEPH4JrxqOgy91XW1cnqGmrIqiag2sZX8rhc41g6daIuLg/132, createdBy=ad2d2367463, createdName=王振超, createdTime=Sun Mar 06 22:19:58 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077022, encodeId=f55a10e702281, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:29 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076431, encodeId=5d8610e6431b3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 03 07:02:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075676, encodeId=1eca10e567684, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:07 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-05 微探

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1227258, encodeId=b27f122e258aa, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b173099865, createdName=xuexuehong, createdTime=Sat Jun 18 20:53:22 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200063, encodeId=351e12000634b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKic4Sia2vW3FdKIZE7aLtjvkgUXebicPbmmEPH4JrxqOgy91XW1cnqGmrIqiag2sZX8rhc41g6daIuLg/132, createdBy=ad2d2367463, createdName=王振超, createdTime=Sun Mar 06 22:19:58 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077022, encodeId=f55a10e702281, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:29 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076431, encodeId=5d8610e6431b3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 03 07:02:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075676, encodeId=1eca10e567684, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:07 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-03 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1227258, encodeId=b27f122e258aa, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b173099865, createdName=xuexuehong, createdTime=Sat Jun 18 20:53:22 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200063, encodeId=351e12000634b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKic4Sia2vW3FdKIZE7aLtjvkgUXebicPbmmEPH4JrxqOgy91XW1cnqGmrIqiag2sZX8rhc41g6daIuLg/132, createdBy=ad2d2367463, createdName=王振超, createdTime=Sun Mar 06 22:19:58 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077022, encodeId=f55a10e702281, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:29 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076431, encodeId=5d8610e6431b3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 03 07:02:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075676, encodeId=1eca10e567684, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:07 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-01 微探

    学习学习

    0

相关指南

前列腺癌患者的营养治疗专家共识

中国抗癌协会肿瘤营养专业委员会 · 2021-10-09

2021 共识声明：前列腺癌质子治疗

国外肿瘤科相关专家小组（统称） · 2021-04-12

德国介入放射学会 (DeGIR) 关于前列腺动脉栓塞的立场文件

德国介入放射学会 (DeGIR) · 2020-11-05

2021NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗激素敏感性转移性前列腺癌

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-10-28

FDA指导原则：非转移性去势抵抗性前列腺癌：临床试验中无转移生存终点的考虑

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2021-10-01

前列腺癌睾酮管理中国专家共识(2021版)

中华医学会泌尿外科学分会(CUA) · 2021-04-30

拓展阅读

2010 ACS 前列腺癌早期筛查指南

美国癌症学会(ACS,American Cancer Society) · 2010-03-01

2010CCO 前列腺癌根治性前列腺切除术病理T3或边缘阳性的辅助放射治疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-04-15

ESMO临床实践指南：前列腺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

2008 前列腺癌骨转移临床诊疗专家共识（2008版）

恶性肿瘤骨转移及骨相关疾病临床诊疗专家组 · 2010-05-01

2011EAU前列腺癌诊疗指南

欧洲泌尿外科学会(EAU,European Association of Urology) · 2011-01-01

前列腺癌诊断标准

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-07-01